-
Something wrong with this record ?
New method for recognition of sterol signalling molecules: methinium salts as receptors for sulphated steroids
Z. Kejík, T. Bříza, J. Králová, I. Mikula, P. Poučková, P. Martásek, V. Král,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Benzothiazoles chemistry MeSH
- Cholesterol Esters chemistry pharmacology MeSH
- Estrone analogs & derivatives chemistry pharmacology MeSH
- Heterocyclic Compounds chemistry pharmacology MeSH
- Carbocyanines chemistry MeSH
- Mice, Nude MeSH
- Breast Neoplasms drug therapy MeSH
- Pregnenolone chemistry pharmacology MeSH
- Antineoplastic Agents pharmacology MeSH
- Xenograft Model Antitumor Assays MeSH
- Animals MeSH
- Check Tag
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
In this work, we studied indolium and benzothiazolium pentamethine salts 1-3 as novel type of receptors for the recognition of sulphated signalling molecules (sulphated steroids: oestrone, pregnenolone and cholesterol sulphate). A recognition study was performed in an aqueous medium (1mM phosphate buffer (H2O:MeOH; 99:1 (v/v))) at pH 7.34. The tested salts displayed a high affinity for these sulphated analytes, mainly for cholesterol sulphate. However, no interaction between the salts and control, non-sulphated sterol analytes (cholesterol and bile acid) was observed. The highest affinity for the sulphated steroids was observed for benzothiazole salt 1. This salt also displayed different spectral behaviour from that observed for carbocyanine salts 2 and 3. In this presence of cholesterol sulphate, benzothiazole salt 1 displayed significant spectral changes depending on the medium used: a blue shift in the aqueous medium and a red shift in the methanolic one (H2O:MeOH; 2:1 (v/v)). Subsequently preliminary in vivo study showed that, salt 1 significantly inhibits a growth of breast carcinoma on Nu/nu mice model.
1st Faculty of Medicine Charles University Prague Kateřinská 32 121 08 Prague 2 Czech Republic
Institute of Chemical Technology Technická 5 166 28 Prague 6 Czech Republic
Zentiva Development U Kabelovny 130 102 37 Prague 10 Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000478
- 003
- CZ-PrNML
- 005
- 20160127120216.0
- 007
- ta
- 008
- 160108s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.steroids.2014.10.009 $2 doi
- 035 __
- $a (PubMed)25478679
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kejík, Zdeněk $u Institute of Chemical Technology, Technická 5, 166 28 Prague 6, Czech Republic; First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08 Prague 2, Czech Republic.
- 245 10
- $a New method for recognition of sterol signalling molecules: methinium salts as receptors for sulphated steroids / $c Z. Kejík, T. Bříza, J. Králová, I. Mikula, P. Poučková, P. Martásek, V. Král,
- 520 9_
- $a In this work, we studied indolium and benzothiazolium pentamethine salts 1-3 as novel type of receptors for the recognition of sulphated signalling molecules (sulphated steroids: oestrone, pregnenolone and cholesterol sulphate). A recognition study was performed in an aqueous medium (1mM phosphate buffer (H2O:MeOH; 99:1 (v/v))) at pH 7.34. The tested salts displayed a high affinity for these sulphated analytes, mainly for cholesterol sulphate. However, no interaction between the salts and control, non-sulphated sterol analytes (cholesterol and bile acid) was observed. The highest affinity for the sulphated steroids was observed for benzothiazole salt 1. This salt also displayed different spectral behaviour from that observed for carbocyanine salts 2 and 3. In this presence of cholesterol sulphate, benzothiazole salt 1 displayed significant spectral changes depending on the medium used: a blue shift in the aqueous medium and a red shift in the methanolic one (H2O:MeOH; 2:1 (v/v)). Subsequently preliminary in vivo study showed that, salt 1 significantly inhibits a growth of breast carcinoma on Nu/nu mice model.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a benzothiazoly $x chemie $7 D052160
- 650 _2
- $a nádory prsu $x farmakoterapie $7 D001943
- 650 _2
- $a karbocyaniny $x chemie $7 D002232
- 650 _2
- $a estery cholesterolu $x chemie $x farmakologie $7 D002788
- 650 _2
- $a estron $x analogy a deriváty $x chemie $x farmakologie $7 D004970
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a heterocyklické sloučeniny $x chemie $x farmakologie $7 D006571
- 650 _2
- $a myši nahé $7 D008819
- 650 _2
- $a pregnenolon $x chemie $x farmakologie $7 D011284
- 650 _2
- $a xenogenní modely - testy protinádorové aktivity $7 D023041
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bříza, Tomáš $u Institute of Chemical Technology, Technická 5, 166 28 Prague 6, Czech Republic; First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08 Prague 2, Czech Republic.
- 700 1_
- $a Králová, Jarmila $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
- 700 1_
- $a Mikula, Ivan $u First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08 Prague 2, Czech Republic.
- 700 1_
- $a Poučková, Pavla $u First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08 Prague 2, Czech Republic.
- 700 1_
- $a Martásek, Pavel $u First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 121 08 Prague 2, Czech Republic.
- 700 1_
- $a Král, Vladimír $u Institute of Chemical Technology, Technická 5, 166 28 Prague 6, Czech Republic; Zentiva Development (part of Sanofi Generic group), U Kabelovny 130, 102 37 Prague 10, Czech Republic. Electronic address: vladimir.kral@vscht.cz.
- 773 0_
- $w MED00004438 $t Steroids $x 1878-5867 $g Roč. 94, č. - (2015), s. 15-20
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25478679 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20160127120340 $b ABA008
- 999 __
- $a ok $b bmc $g 1102759 $s 924684
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 94 $c - $d 15-20 $e 20141202 $i 1878-5867 $m Steroids $n Steroids $x MED00004438
- LZP __
- $a Pubmed-20160108